Wolverine Asset Management LLC lifted its position in shares of Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU – Get Rating) by 126.6% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 22,366 shares of the company's stock after buying an additional 12,495 shares during the quarter. Wolverine Asset Management LLC's holdings in Phoenix Biotech Acquisition were worth $225,000 at the end of the most recent quarter.

Separately, Spartan Fund Management Inc. purchased a new stake in shares of Phoenix Biotech Acquisition during the 1st quarter worth about $629,000.

Phoenix Biotech Acquisition Price Performance

Phoenix Biotech Acquisition stock opened at $10.15 on Tuesday. The stock's 50 day moving average price is $10.11 and its 200 day moving average price is $10.09. Phoenix Biotech Acquisition Corp. has a one year low of $9.94 and a one year high of $11.21.

Phoenix Biotech Acquisition Profile

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe.

Featured Stories

• Get a free copy of the StockNews.com research report on Phoenix Biotech Acquisition (PBAXU)
• Here's Why Harley-Davidson is Roaring Higher
• As Mega Caps Get Crushed, This Mid Cap Tech Stock Is Crushing It
• Is The Meta Platforms Stock Meltdown a Rare Buying Opportunity?
• Why Investors Are Suddenly Excited About Vaxcyte
• Saia Stock Is Ready To Switch Gears And Move Higher

Receive News & Ratings for Phoenix Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phoenix Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.